Loading...
XFRACNW
Market cap6mUSD
Sep 30, Last price  
0.25EUR
Name

CoDon AG

Chart & Performance

D1W1MN
XFRA:CNW chart
P/E
—
P/S
0.67
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
7.36%
Revenues
10m
+57.28%
00119,676,11300002,693,0004,045,0004,510,0005,155,0005,622,0005,980,2195,696,0006,856,0006,233,0009,803,000
Net income
-9m
L-32.79%
00-144,391,5580000-2,381,000-2,684,000-2,493,000-2,866,000-3,650,000-7,054,253-6,271,000-12,629,000-13,869,000-9,321,000
CFO
-8m
L-15.90%
00000-2,334,065-1,564,342-2,108,000-2,974,000-3,617,000-5,878,485-8,138,000-9,529,000-9,457,000-7,953,000

Profile

co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
URL
https://www.codon.de/
IPO date
Feb 01, 2001
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
9,803
57.28%
Cost of revenue
2,474
Unusual Expense (Income)
NOPBT
7,329
NOPBT Margin
74.76%
Operating Taxes
186
Tax Rate
2.54%
NOPAT
7,143
Net income
(9,321)
-32.79%
Dividends
Dividend yield
Proceeds from repurchase of equity
6,316
BB yield
-16,869.86%
Debt
Debt current
476
Long-term debt
8,016
Deferred revenue
Other long-term liabilities
(1,000)
Net debt
1,952
Cash flow
Cash from operating activities
(7,953)
CAPEX
(498)
Cash from investing activities
(498)
Cash from financing activities
5,863
FCF
7,668
Balance
Cash
6,540
Long term investments
62
Excess cash
6,050
Stockholders' equity
18,101
Invested Capital
17,763
ROIC
24.36%
ROCE
30.77%
EV
Common stock shares outstanding
23
Price
1.64
33.88%
Market cap
37
-99.82%
EV
1,990
EBITDA
8,553
EV/EBITDA
0.23
Interest
880
Interest/NOPBT
12.01%